Pegylated interferon alfa-2b plus ribavirin for treatment of chronic hepatitis C

AIM: To study the safety and efficacy of pegylated interferon alfa-2b, indigenously developed in India, plus ribavirin in treatment of hepatitis C virus (HCV). METHODS: One-hundred HCV patients were enrolled in an open-label, multicenter trial. Patients were treated with pegylated interferon alfa-2b...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Rao, PN, Koshy, Abraham, Philip, Jacob, Premaletha, Narayanan, Varghese, Joy, Narayanasamy, Krishnasamy, Mohindra, Samir, Pai, Nitin Vikas, Agarwal, Manoj Kumar, Konar, Ashoknanda, Vora, Hasmukh B
Format: Artigo
Langue:Inglês
Publié: Baishideng Publishing Group Inc 2014
Sujets:
Clinical Trials Study
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4110544/
https://ncbi.nlm.nih.gov/pubmed/25068004
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v6.i7.520
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires